Investing in Life Science Innovation - TVM Capital Life Science Venture Capital %

Making investments to transform healthcare

Supporting breakthrough therapies and medical products that benefit patients and the healthcare system.

About us
Funding novel, disruptive life science innovations

We provide capital and expertise to develop and market products with the potential to transform medical practice while building value for our investors.

About us
Driving an industry breakthrough investment strategy

Our approach sets us apart.

About us
„Sind Ideen immer Risiko?“ – Das neue Kapital

Wir fördern Zukunftsfinanzierung gemeinsam mit dem Bundesverband Beteiligungskapital e.V.

Watch the video on youtube

Our mission is to invest in the development of exciting life science products and the growth of companies to become innovative leaders in their market segment. As true partners, we work closely with our portfolio companies, striving to enable their ideas and bring new therapies and medical products to market. Our track record of successful collaborations highlights our partnership and value-building approach.

About us

Our Approach

We have a unique two-pronged strategy. The first is the financing of innovative early-stage therapeutics through a single asset company approach that leverages our strategic relationship with global pharmaceutical firm Eli Lilly and Company. The second is to invest in differentiated commercial-stage medtech, diagnostics, and digital health products as well as late-stage therapeutics.

Strategy & Approach